Catch up on the top radiology content of the past week.
News|Slideshows|March 27, 2025
Emerging Research and News in Prostate Cancer Imaging — March 2025
Author(s)Diagnostic Imaging Staff
Catch up on the most-well viewed prostate imaging content in March 2025.
Advertisement
Touching on a variety of topics in prostate cancer imaging, ranging from monitoring of prostate MRI exams to reduce contrast use to a new meta-analysis on AI and bpMRI for csPCa detection and FDA approval of Gozellix for the preparation of the PSMA PET agent 68Ga gozetotide, here are the top five most well-viewed prostate imaging content from Diagnostic Imaging for March 2025.
Advertisement
Related to this article
Catch up on the top radiology content of the past week.
Catch up on the top radiology content of the past week.
Catch up on the top radiology content of the past week.
A deep learning model developed for predicting BI-RADS assessments from dynamic contrast-enhanced (DCE) breast MRI had over a 14 percent lower AUC than radiologist evaluation in external validation testing.
Catch up on a variety of FDA news in radiology from the past week.
In a recent interview, Stamatia Destounis, MD, FACR, shared her perspective on recent changes to the BI-RADS system, offering insights on contrast-enhanced mammography, reporting changes for breast MRI and ultrasound, and the importance of auditing for BI-RADS category 3 assessments.
Catch up on a variety of FDA news in radiology from the past week.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
What New CT and MRI Research May Reveal About Bone Loss, Diabetes and Cognitive Decline
2
Can Brain MRI Surveillance Alone Be Advantageous in Monitoring Cognition for Patients with SCLC?
3
The Grouser in the Radiology Reading Room
4
Radiology Roundup of FDA News: September 20 — September 26
5